The Value of miR-296 and miR-517c in Evaluating the Prognosis of Patients with Glioma after Radiotherapy and Chemotherapy

Table 1

Expression comparison of miR-296 in gliomas with different pathological features.

Clinicopathological features	n	miR-296 expression quantity	t
Gender
Male	388	3.62 ± 0.89	0.601	0.548
Female	344	3.58 ± 0.91
Age (years)
<50	386	2.91 ± 0.73	1.246	0.213
≥50	346	2.84 ± 0.79
Degree of differentiation
Low	331	2.44 ± 0.16	1.109	0.268
High	401	2.48 ± 0.64
Pathological grading
I–II	376	2.92 ± 0.25	12.121	<0.001
III–IV	356	2.74 ± 0.13
Infiltration depth
≤1/2	421	1.81 ± 0.67	5.920	<0.001
>1/2	311	2.05 ± 0.29